Category: Cannabis Studies

Peer-reviewed studies covering cannabis and cannabis compounds.

Cannabis Use Linked to Lower Inflammation Among People With HIV or Methamphetamine Disorder

A new study led by researchers at San Diego State University and the University of California San Diego finds that cannabis use may help reduce inflammation in individuals with HIV and those with a history of methamphetamine use disorder (MUD). The research, published in the journal Viruses, involved 234 participants, including 86 people with HIV …

Continue reading

Study: THC and CBD Reduce Chemotherapy-Induced Nerve Pain, Improve Daily Function

Researchers at Tel Aviv Sourasky Medical Center have found that medical cannabis significantly eases chemotherapy-induced peripheral neuropathy (CIPN), a common and often debilitating side effect of cancer treatment. The study analyzed patient-reported outcomes from 751 individuals treated through the medical cannabis provider Tikun Olam. Participants reported symptoms such as burning, numbness, cold sensations, and prickling …

Continue reading

Study Explores Cannabis Compounds as Potential Tools Against COVID-19

Researchers from China’s Ministry of Agriculture and Rural Affairs and the Chinese Academy of Agricultural Science have reviewed evidence suggesting cannabis-derived compounds may hold therapeutic value in addressing COVID-19 and other respiratory infections. The review, published in the journal Foods, highlights that while vaccines remain central in controlling the spread of SARS-CoV-2, they are not …

Continue reading

Harvard Study: CBD Reduces Anxiety Symptoms in Pilot Clinical Trial

A new pilot clinical trial led by Harvard Medical School researchers finds that CBD may significantly reduce anxiety symptoms while also improving mood, sleep, and quality of life. The open-label study, published in Biomedicines, enrolled 12 patients with moderate to severe anxiety. Over six weeks, participants self-administered a full-spectrum, hemp-derived CBD sublingual solution containing 30 …

Continue reading

CBD Shows Unique Survival Benefit in Pancreatic Cancer Model, States Study

A new study published in the International Journal of Molecular Sciences provides fresh evidence that cannabidiol (CBD) could play a distinctive role in the treatment of pancreatic ductal adenocarcinoma (PDAC), one of the most aggressive and deadly cancers. Researchers from the University of Parma, University College Cork, The University of Western Australia, and Curtin University …

Continue reading

Study: CBD May Boost Effectiveness of EGFR Inhibitors in Treating Oral Cancer

Researchers from the Maurice Wilkins Centre and Auckland University of Technology have reviewed evidence suggesting that cannabidiol (CBD) could improve outcomes for patients with oral squamous cell carcinoma (OSCC) when paired with epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR-TKIs). Researchers note that OSCC, which represents the vast majority of head and neck squamous cell carcinomas …

Continue reading

Study: Medical Marijuana Improves Sleep and Anxiety in Insomnia Patients

A study published today by PLOS Mental Health finds that medical marijuana may provide relief for people struggling with chronic insomnia, improving both sleep quality and related symptoms like anxiety. The analysis, conducted by researchers at Imperial College London, examined data from 124 patients enrolled in the UK Medical Cannabis Registry who were prescribed cannabis-based …

Continue reading

Cannabis May Reduce Alcohol Cravings and Consumption, Study Finds

A new study published in the peer-reviewed journal Drug and Alcohol Dependence finds that cannabis could help reduce alcohol intake among some heavy drinkers. Researchers from Colorado State University and the University of Colorado Boulder conducted the first controlled laboratory experiment examining the effects of legal-market cannabis on drinking behavior.

Continue reading

Study: CBD May Improve Memory and Reduce Inflammation in Alzheimer’s Patients

A study from the University of Haifa, published in the journal Neuropsychopharmacology, has found that cannabidiol (CBD) reduced both cognitive decline and neuroinflammation in an animal model of Alzheimer’s disease. For the study, researchers worked with rats bred to mimic Alzheimer’s disease, which caused memory loss, reduced social interaction, and brain changes linked to the …

Continue reading

Clinical Trial: Psilocybin-Assisted Psychotherapy Reduces Depression and Anxiety in Patients With Life-Threatening Illness

In a phase 2b randomized controlled trial, psilocybin-assisted psychotherapy provided significant and lasting relief from depression and anxiety in people with life-threatening illnesses. The study, conducted by researchers from St. Vincent’s Hospital Melbourne, Swinburne University, and the University of Melbournem, enrolled 35 participants between 18 and 80 who were experiencing clinically significant depression or anxiety. …

Continue reading